ArticleThe Journal of biological chemistry2013

Converting nonhydrolyzable nucleotides to strong cystic fibrosis transmembrane conductance regulator (CFTR) agonists by gain of function (GOF) mutations.

George Okeyo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.